Welcome to our Chinese medicine and acupuncture research news pages. We add to the content of these pages continuously as more research news comes in. Browse through the complete archive below or use the category links on the right.
Please note that the most twenty recent research archive items are free to view but access to the thousands of items in the archive require a journal subscription.
Korean authors have carried out a systematic review of acupuncture for the treatment of essential hypertension. Twenty trials were included, of which only three were considered relatively rigorous. Acupuncture achieved significant...
A systematic review of the literature on the effect of tai chi exercise on blood pressure (BP) suggests that it may reduce BP and serve as a practical, non-pharmacological adjunct to conventional hypertension management. Of the 26...
The Susan Samueli Center for Integrative Medicine at the University of California has received a $2 million, five-year federal grant to continue studying how acupuncture can help treat cardiovascular illnesses such as heart...
The effects of acupuncture as an add-on to conventional antihypertensive management methods (medication and/or lifestyle modification) were investigated.
In a trial of 192 subjects with hypertension (between 140/90 and 179/109 mmHg), given up to twelve acupuncture treatments over six to eight weeks, no difference in effect was found between standardised (formula) acupuncture, individualised acupuncture and invasive sham acupuncture (needling non-points).
A rigorous, randomised, single-blind, Western trial comparing acupuncture with sham needling suggests that acupuncture may decrease blood pressure in hypertensive patients by a similar amount to that achieved using pharmaceutical therapy.
A kampo (traditional Japanese herbal medicine) made from four herbs: Huang Lian (Coptidis Rhizoma), Huang Qin (Scutellariae Radix), Zhi Zi (Gardeniae Fructus) and Huang Bai (Cortex Phellodendri) was found to be significantly more effective than placebo in controlling hypertension symptoms in a double-blind, placebo-controlled trial.